Internal Quality Assurance Study Confirms The CMSP:B-5™ as a Reliable Early Childhood Communication Measure TEMECULA, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Melospeech, Inc. has completed an internal study evaluating their Communication Milestone Screening Protocol: Birth to Five (CMSP:B-5)™, an...

Melospeech Inc. Takes Silver for Innovation at Best in Biz Awards Melospeech® wins Silver for Most Innovative Company of the Year – Small (1-99 employees) at Best in Biz Awards 2024 for its groundbreaking AI innovations.

Melospeech Inc. revolutionizes speech therapy with launch of SLPeaceBot™ and CMSP:B-5 Melospeech Inc. launches award-winning tools, SLPeaceBot™ & CMSP:B-5, empowering providers to streamline care and improve outcomes.